XLRN
Acceleron Pharma Inc
Price:  
178.75 
USD
Volume:  
7,201,419.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Acceleron Relative Valuation

-160.0%
Upside

As of 2024-06-15, the Relative Valuation of Acceleron Pharma Inc (XLRN) is (107.21) USD. This relative valuation is based on P/E multiples. With the latest stock price at 178.75 USD, the upside of Acceleron Pharma Inc based on Relative Valuation is -160.0%.

The range of the Relative Valuation is (100.12) - (109.74) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 23.7x - 30.4x 29.6x
Forward P/E multiples 19.4x - 26.0x 21.2x
Fair Price (100.12) - (109.74) (107.21)
Upside -156.0% - -161.4% -160.0%
178.75 USD
Stock Price
(107.21) USD
Fair Price

Acceleron Relative Valuation - Historical P/E Data

Date P/E